These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 12001593)

  • 1. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    Dohmen W; Fuchs W
    MMW Fortschr Med; 2005 Mar; 147(9):39. PubMed ID: 15794353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 3. Atazanavir not to be used with proton pump inhibitors.
    AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Safety of proton pump inhibitors for long-term application].
    Kuipers E
    Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
    [No Abstract]   [Full Text] [Related]  

  • 5. All PPIs equivalent for treatment of GERD.
    J Fam Pract; 2005 Dec; 54(12):1024. PubMed ID: 16370078
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Poppy seeds' in stomach aspirates: is oral omeprazole extemporaneous dispersion bioavailable?
    Tuleu C; Arenas-Lopez S; Robinson C; McCarthy D; Paget RI; Tibby S; Taylor KM
    Eur J Pediatr; 2008 Jul; 167(7):823-5. PubMed ID: 17641912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
    Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
    J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
    Meineche-Schmidt V
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical inquiries. Is the long-term use of proton pump inhibitors safe?
    Malaty W; Stigleman S; Mayer J; Guthmann RA
    J Fam Pract; 2004 Sep; 53(9):740-2. PubMed ID: 15353165
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new interesting study on coxib].
    Carlqvist M; Ohlén K
    Lakartidningen; 2003 Apr; 100(14):1261. PubMed ID: 12756658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proton pump inhibitors in bleeding stomach ulcer?].
    Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2006 Mar; 168(10):1024-6. PubMed ID: 16522294
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY; Shin HS; Bae SK; Lee MG
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA; Babkova IV; Mikhalev AI
    Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.
    Horn JR; Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():20-4. PubMed ID: 16303033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of proton pump inhibitors. In vivo is decisive].
    MMW Fortschr Med; 2002 Mar; 144(13):51. PubMed ID: 12001593
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.
    Gremse DA; Donnelly JR; Kukulka MJ; Lloyd E; Lee C
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1211-5. PubMed ID: 15153174
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.